Hcp Live
MD Magazine
United States
Contact Hcp
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Hcp:
Diagnosing and Assessing AD in Patients With Skin of Color
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved. → Read More
Applying Real-World Evidence in the Management of CAD/PAD
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician… → Read More
Yehuda Handelsman, MD: The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease Preview
The TMIOA Medical Director highlights the best sessions, new topics, and growing discussion around the 18th annual congress. → Read More
Management of nr-AxSpA: Emerging Agents and IFAA
Novel agents in the pipeline for the management of nr-AxSpA and the goals of the International Foundation for Autoimmune & Autoinflammatory Arthritis (IFAA). → Read More
C-AXSPAND Study in nr-axSpA
A review of the C-AXSPAND study on the only FDA-approved therapy for nr-AxSpA, certolizumab pegol, and its safety profile during pregnancy. → Read More
Goals of Therapy for Inflammatory Bowel Disease
David T. Rubin, MD, highlights what the goals of therapy are when caring for patients with an inflammatory bowel disease. → Read More
Diagnosing Inflammatory Bowel Disease
Drs Jessica R. Allegretti and Marla C. Dubinsky recognize challenges identifying inflammatory bowel disease from other conditions and suggest strategies that can help clinicians accurately diagnose patients. → Read More
Rationale for Biologics to Treat Psoriatic Arthritis
Grace Wright, MD, highlights the different classes of biologics, including TNF inhibitors, IL-12/23 inhibitors, and IL-17A inhibitors, to treat psoriatic arthritis. → Read More
Psoriatic Arthritis: Current Treatment Recommendations
Therapeutic options for the treatment of psoriatic arthritis are outlined as well as factors that guide treatment decisions. → Read More
Treatment Strategies for nr-axSpA
Approaching treatment of mild to severe nr-axSpA through NSAIDs, older disease-modifying drugs, and steroids. → Read More
Prodrug Therapy for ADHD
Special considerations when treating attention-deficit/hyperactivity disorder with a stimulant, and the rationale for using prodrug therapy. → Read More
Inflammatory Bowel Disease Risk Stratification
Jessica R. Allegretti, MD, MPH, explains how to accurately risk stratify patients with inflammatory bowel disease, with special considerations regarding extraintestinal manifestations. → Read More
Recommendations for Using LAIs During COVID-19
Recommendations for patients receiving LAIs for the treatment of schizophrenia during the COVID-19 pandemic. → Read More
Overcoming Barriers With LAIs in Schizophrenia Management
Insight on why LAIs are underprescribed and overcoming barriers to adoption for patients who have schizophrenia. → Read More
Early Initiation of LAIs in Treating Schizophrenia
The importance of early initiation of LAIs for relapse prevention and the treatment of schizophrenia. → Read More
Assessment of A 31-Year-Old Woman With Psoriatic Arthritis
Rheumatologist Grace Wright, MD, reviews the diagnostic work-up for a 31-year-old woman who presented with symptoms of psoriatic arthritis and discusses the goals of therapy. → Read More
Comorbidities in Rheumatoid Arthritis
Common comorbidities associated with rheumatoid arthritis and strategies to help optimize patient outcomes. → Read More
Long-Acting Stimulants for ADHD
David W. Goodman, MD, and Timothy E. Wilens, MD, elaborate on the use of long-acting stimulants for the treatment of attention deficit hyperactivity disorder. → Read More
Short- and Intermediate-Acting Stimulants for ADHD
Ann C. Childress, MD, highlights the use of short- and intermediate-acting stimulants as treatment for appropriate patients with attention deficit hyperactivity disorder, discussing what is available and how to properly dose and administer to patients. → Read More
Trials of Interest in Heart Failure
A summary of clinical trials currently exploring additional therapeutic strategies for use in heart failure. → Read More